Pelicon Pharmaceutical Pvt Ltd

Pharmaceutical company manufacturing and trading medicines and pharmaceutical preparations since 1980.

1980 | 24 Parganas, West Bengal (India) | Active
Last Updated:

Pelicon Pharmaceutical Profile

Key Indicators

  • Authorised Capital ₹ 2.50 M
  • Paid Up Capital ₹ 2.40 M
  • Company Age 44 Year, 6 Months
  • Last Filing with ROC 31 Mar 2024
  • Satisfied Charges ₹ 4.64 Cr
  • Revenue Growth %
  • Profit Growth 2772.51%
  • Ebitda -14680.90%
  • Net Worth 3847.32%
  • Total Assets 272.95%

About Pelicon Pharmaceutical

Pelicon Pharmaceutical Pvt Ltd (PPPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 September 1980 and has a history of 44 years and six months. Its registered office is in 24 Parganas, West Bengal, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.40 M.

The company has closed loans amounting to ₹4.64 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.

Ratan Sarawagi and Suman Sarawagi serve as directors at the Company.

Company Details

  • Location

    24 Parganas, West Bengal, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24231WB1980PTC032999

  • Company No.

    032999

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    18 Sep 1980

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Kolkata

Industry

Pharma
Company report

Pelicon Pharmaceutical Pvt Ltd

Explore comprehensive data for Pelicon Pharmaceutical Pvt Ltd, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Pelicon Pharmaceutical?

Board Members (2)

NameDesignationAppointment DateStatus
Ratan Sarawagi Country flag representing In Director 16-Nov-2017Current
Suman Sarawagi Country flag representing In Director 01-Dec-2018Current

Financial Performance of Pelicon Pharmaceutical.

Pelicon Pharmaceutical Pvt Ltd, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 2772.51% increase in profit. The company's net worth Soared by an impressive increase of 3847.32%.

Pelicon Pharmaceutical revenue growth over time
Pelicon Pharmaceutical profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
272.95%
Profit or Loss
2772.51%
Net Worth
3847.32%
EBITDA
-14680.90%

What is the Ownership and Shareholding Structure of Pelicon Pharmaceutical?

Unlock access to Pelicon Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹46.40 M

Charges Breakdown by Lending Institutions

  • State Bank Of India : 2.88 Cr
  • Bank Of Baroda : 1.76 Cr

Latest Charge Details

DateLenderAmountStatus
31 Oct 2005State Bank Of India₹2.88 CrSatisfied
10 Sep 2003Bank Of Baroda₹1.76 CrSatisfied

How Many Employees Work at Pelicon Pharmaceutical?

Unlock and access historical data on people associated with Pelicon Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Pelicon Pharmaceutical Pvt Ltd

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Pelicon Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pelicon Pharmaceutical's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Pelicon Pharmaceutical

Recent activity within the organization

  • Annual General Meeting

    Pelicon Pharmaceutical Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Pelicon Pharmaceutical Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata.

  • Director Appointment

    Suman Sarawagi was appointed as a Director was appointed as a Director on 01 Dec 2018 & has been associated with this company since 6 years 4 months .

  • Director Appointment

    Ratan Kumar Sarawagi was appointed as a Director was appointed as a Director on 16 Nov 2017 & has been associated with this company since 7 years 4 months .

  • Charges

    A charge registered on 31 Oct 2005 via Charge ID 90249386 with State Bank Of India was fully satisfied on 27 Jan 2017.

  • Charges

    A charge registered on 10 Sep 2003 via Charge ID 90249290 with Bank Of Baroda was fully satisfied on 04 Aug 2015.

Frequently asked questions

  • What is the Incorporation or founding date of Pelicon Pharmaceutical Pvt Ltd?

    Pelicon Pharmaceutical Pvt Ltd was incorporated on 18 Sep 1980.

  • What is authorized share capital and paid-up capital of Pelicon Pharmaceutical Pvt Ltd?

    The authorized share capital of Pelicon Pharmaceutical Pvt Ltd is ₹ 2.50 M and paid-up capital is ₹ 2.40 M.

  • Who are the current board members & directors of Pelicon Pharmaceutical Pvt Ltd?

    Currently 2 directors are associated with Pelicon Pharmaceutical Pvt Ltd.

    • Ratan Kumar Sarawagi
    • Suman Sarawagi

  • What is the registered address of Pelicon Pharmaceutical Pvt Ltd?

    As per Ministry of Corporate Affairs (Mca), the registered address of Pelicon Pharmaceutical Pvt Ltd is Vill- P.O- Kanganberia P.S. Bishnupur India, Nandabhanga, West Bengal, 743503.

  • What is the corporate identification number (CIN) and company number of Pelicon Pharmaceutical Pvt Ltd?

    The corporate identification number (CIN) of Pelicon Pharmaceutical Pvt Ltd is U24231WB1980PTC032999 and the company number is 032999 as per Ministry of Corporate Affairs (MCA).

  • What change has been observed in the net worth of Pelicon Pharmaceutical Pvt Ltd, and by what percentage?

    The financial reports for the fiscal year 2022 indicates that The net worth of Pelicon Pharmaceutical Pvt Ltd has experienced an upsurge of 3847.32%.

  • When was the last Balance Sheet of Pelicon Pharmaceutical Pvt Ltd filed with the ROC?

    The most recent Balance Sheet for Pelicon Pharmaceutical Pvt Ltd was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Drug Formulation & Development